GeneDisco: A Benchmark for Experimental Design in Drug Discovery
Published in ICLR, 2022
Recommended citation: Mehrjou A, Soleymani A, Jesson A, Notin P, Gal Y, Bauer S, Schwab P. GeneDisco: A Benchmark for Experimental Design in Drug Discovery. arXiv preprint arXiv:2110.11875. 2021 Oct 22. https://tinyurl.com/3nec97kb
We introduce GeneDisco, an open benchmark suite for batch active learning for drug discovery that provides curated datasets, tasks, performance evaluation and open source implementations of state-of-the-art algorithms for experimental exploration.
- We perform an extensive experimental baseline evaluation that establishes the relative performance of existing state-of-the-art methods on all the developed benchmark settings using a total of more than 20 000 central processing unit (CPU) hours of compute time.
- We survey and analyse the current state-of-the-art of active learning for biological exploration in the context of the generated experimental results, and present avenues of heightened potential for future research based on the developed benchmark.
Leave a Comment